P&G Defends Tooth-Whitening Cosmetic Classification In FDA Letter
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble urges FDA to deny a citizen petition by the American Dental Association to reclassify commercially available tooth whiteners as drugs, saying the petition is motivated by the financial interests of ADA members